This site uses cookies to give you a better browsing experience. By continuing to use this website, you accept our use of these cookies. For more information, see our Privacy and Cookie Notice.

Skip to main content
alt text

News & Media

Take a look inside our world

Feature stories

alt text

COVID-19 Updates and Resources

Read more
alt text

Creating an Effective Morning Routine with Depression

Read more
alt text

Antibiotics Aren’t Always the Solution

Read more
alt text

Teva and the Weizmann Institute of Science enter into collaboration to identify the next generation ...

Read more
alt text

Teva and Tel Aviv University sign a collaboration agreement for innovative R&D in the fields of canc...

Read more
alt text

Mount Sinai Publishes New Research Highlighting Novel Method to Identify Patterns Among Patients wit...

Read more
alt text

Christoph Stoller Appointed as new President of Medicines for Europe

Read more
alt text

Saving Billions While Fueling Economies: Teva’s First-Ever Global Economic Impact Report

Discover more
alt text

All Feature Stories

Discover more
alt text

All Press Releases

Discover more

Connect with us on social media


Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Teva Social Media Guidelines

Connect with us

Contacts for Media Inquiries

Kelley Dougherty

Corporate Communications North America

+1-973-658-0237
Kelley.Dougherty@tevapharm.com

Yonatan Beker

Corporate Communications Israel

+972-3-9187869
Yonatan.Beker@tevapharm.com

Smadar Tabenkin-Ezer

Corporate Communications International Markets

+972-3-9062305
Smadar.Tabenkin-Ezer01@teva.co.il

Leslie McGibbon

Corporate Communications Europe

Leslie.Mcgibbon@Tevaeu.com